The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.
Most of the public is probably unaware that similar to the current COVID-19 injections that are not yet approved by the FDA, but only given Emergency Use Authorization, so too the hundreds of diagnostic tests that supposedly detect COVID-19 are also NOT approved by the FDA, but only authorized via an EUA.
What is the reason the CDC is withdrawing its EUA request for the Real-Time RT-PCR Diagnostic Panel?
“CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.”
So there you have it. The CDC just basically admitted that many of the COVID-19 cases this past year could not be distinguished from “flu cases.”
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed